|
|
Volumn 27, Issue 22, 2009, Pages
|
|
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
TAXANE DERIVATIVE;
ANTINEOPLASTIC AGENT;
BRIDGED COMPOUND;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ESTROGEN RECEPTOR;
PROGESTERONE RECEPTOR;
TAXANE;
TAXOID;
ADULT;
AFRICAN AMERICAN;
AGED;
AXILLARY LYMPH NODE;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER STAGING;
COMPARATIVE STUDY;
DISEASE FREE SURVIVAL;
EUROPEAN AMERICAN;
FEMALE;
FOLLOW UP;
HUMAN;
HUMAN TISSUE;
LETTER;
LYMPH NODE DISSECTION;
MAJOR CLINICAL STUDY;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
TRIPLE RECEPTOR NEGATIVE BREAST CANCER;
AGE;
BREAST TUMOR;
CAUCASIAN;
COHORT ANALYSIS;
ETHNOLOGY;
METABOLISM;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
NOTE;
PATHOLOGY;
PROGNOSIS;
REGISTER;
RISK ASSESSMENT;
SEGMENTAL MASTECTOMY;
STATISTICS;
SURVIVAL;
TREATMENT OUTCOME;
ADULT;
AFRICAN AMERICANS;
AGE FACTORS;
AGED;
ANTHRACYCLINES;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
BRIDGED COMPOUNDS;
COHORT STUDIES;
DISEASE-FREE SURVIVAL;
EUROPEAN CONTINENTAL ANCESTRY GROUP;
FEMALE;
HUMANS;
MASTECTOMY, SEGMENTAL;
MIDDLE AGED;
NEOPLASM STAGING;
PROGNOSIS;
RECEPTOR, ERBB-2;
RECEPTORS, ESTROGEN;
RECEPTORS, PROGESTERONE;
REGISTRIES;
RISK ASSESSMENT;
SURVIVAL ANALYSIS;
TAXOIDS;
TREATMENT OUTCOME;
|
|
EID: 68949094309
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2008.21.5509 Document Type: Letter |
|
Times cited : (21)
|
|
References (7)
|
